Bloodstream infections in patients with solid tumors

References

• Martin GS, Mannino Dm, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-54; PMID:12700374; http://dx.doi.org/10.1056/NEJMoa022139
   PubMed Web of Science ®Google Scholar
• Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attibutable mortality. JAMA 1994; 271:1598-601; PMID:8182812; http://dx.doi.org/10.1001/jama.1994.03510440058033
   PubMed Web of Science ®Google Scholar
• Bos MM, Smeets LS, Dumay I, de Jonge E. Bloodstream infections in patients with or without cancer in a large community hospital. Infection 2013; 41:949-58; PMID:23645474; http://dx.doi.org/10.1007/s15010-013-0468-1
   PubMed Web of Science ®Google Scholar
• Klastersky J. Management of fever in neutropenic patients with different risk of complications. Clin Infect Dis 2004; 39:32-37; http://dx.doi.org/10.1086/383050
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Spanu T, Caira M, Trecarichi EM, Laurenti L, Montuori E, Fianchi L, Leone F, Fadda G, Cauda R et al. Factors associated with mortality in bacteremic patients with hematologic malignancies. Diagn Microbiol Infect Dis 2009; 64:320-6; PMID:19345033; http://dx.doi.org/10.1016/j.diagmicrobio.2009.02.008
   PubMed Web of Science ®Google Scholar
• Gudiol C, Bodro M, Simonetti A, Tubau F, González-Barca E, Cisnal M, Domingo-Domenech E, Jiménez L, Carratalà J. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect 2013; 19:474-9; PMID:22524597; http://dx.doi.org/10.1111/j.1469-0691.2012.03879.x
   PubMed Web of Science ®Google Scholar
• Klastersky J, Ameye L, Maertens J, Georgala A, Muanza F, Aoun M, Ferrant A, Rapoport B, Rolston K, Paesmasn M. Bacteraemia in febrile neutropenia cancer patients. Int J Antimicrob Agents 2007; 30:S51-59.8; PMID:17689933; http://dx.doi.org/10.1016/j.ijantimicag.2007.06.012
   PubMed Web of Science ®Google Scholar
• Velasco E, Byington R, Martins CA, Schirmer M, Dias LM, Gonçalves VM. Comparative study of clinical characteristics of neutropenia and non-neutropenia adult cancer patient with bloodstream infections. Eur J Clin Microiol 2006; 25:1-7. Nine; http://dx.doi.org/10.1007/s10096-005-0077-8
   PubMed Web of Science ®Google Scholar
• Samonis G, Vardakas KZ, Maraki S, Tansarli GS, Dimopoulou D, Kofteridis DP, Angeliki M. Andrianaki, Falagas ME. A prospective study of characteristics and outcomes of bacteremia in patients with solid organ or hematologic malignancies. Support Care Cancer 2013; 21:2521-26.10; http://dx.doi.org/10.1007/s00520-013-1816-5
   PubMed Web of Science ®Google Scholar
• Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with haematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 2003; 36:1103-10.11; http://dx.doi.org/10.1086/374339
   PubMed Web of Science ®Google Scholar
• Velasco E, Byington R, Martins CS, Schirmer M, Dias LC, Gonçalves VM. Bloodstream infection surveillance in a cancer centre: a prospective look at clinical microbiology aspects. Clin Microbiol Infect 2004; 10:542-9; PMID:15191383; http://dx.doi.org/10.1111/j.1469-0691.2004.00874.x
   PubMed Web of Science ®Google Scholar
• Safdar A, Armstrong D. Infectious morbidity in critically ill patients with cancer. Crit Care Clin 2001; 17:531-70, vii-viii; PMID:11525048; http://dx.doi.org/10.1016/S0749-0704(05)70198-6
   PubMed Web of Science ®Google Scholar
• Salvana EMT, Salata RA. Infectious complications associated with monoclonal antibodies and related small molecules. Clin Microbiol Rev 2009; 22: 274-90; PMID:19366915; http://dx.doi.org/10.1128/CMR.00040-08
   PubMed Web of Science ®Google Scholar
• Funakoshi T, Suzuki M, Tamura K. Infectious complications in cancer patients treated with anti-EGFR monoclonal antibodies cetuximab and panitumumab: A systematic review and meta-analysis. Cancer Treat Rev 2014; 40:1221-9; PMID:25288497; http://dx.doi.org/10.1016/j.ctrv.2014.09.002
   PubMed Web of Science ®Google Scholar
• Avritscher EBC, Cooksley CD, Rolston KV, Swint JM, Delclos GL, Franzini L, Swisher SG, Walsh GL, Mansfield PF, Elting LS. Serious postoperative infections following resection of common solid tumors: outcomes, costs, and impact of hospital surgical volume. Support Care Cancer 2014; 22:527-35; PMID:24141699; http://dx.doi.org/10.1007/s00520-013-2006-1
   PubMed Web of Science ®Google Scholar
• Velasco E, Soares M, Byington R, Martins CAS, Scirmer M, Dias LMC, Gonçalves VMS. Prospective evaluation of the epidemiology, microbiology, and outcome of bloodstream infections in adult surgical cancer patients. Eur J Clin Microbiol Infect Dis 2004; 23:596-602; PMID:15322937; http://dx.doi.org/10.1007/s10096-004-1181-x
   PubMed Web of Science ®Google Scholar
• Williams MD, Braun LA, Cooper LM, Johnston J, Weiss RV, Qualy RL, Linde-Zwirble W. Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care. Crit Care 2004; 8:R291-298; PMID:15469571; http://dx.doi.org/10.1186/cc2893
   PubMed Web of Science ®Google Scholar
• Schelenz S, Nwaka D, Hunter PR. Longitudinal surveillance of bacteraemia in haematology and oncology patients at a UK cancer centre and the impact of ciprofloxacin use on antimicrobial resistance. J Antimicrob Chemtother 2013; 68:1431-8; http://dx.doi.org/10.1093/jac/dkt002
   PubMed Web of Science ®Google Scholar
• Marin M, Gudiol C, Ardnauy C, García-Vidal C, Calvo M, Arnan M, Carratalà J. Bloodstream infections in neutropenic patients with cancer: Differences between patients with haematological malignancies and solid tumors. J Infect 2014; 69:417-23; PMID:24960295; http://dx.doi.org/10.1016/j.jinf.2014.05.018
   PubMed Web of Science ®Google Scholar
• Singer C, Kaplan MH, Armstrong D. Bacteremia and fungemia complicating neoplastic disease. Am J Med 1977; 62:731-42; PMID:871128; http://dx.doi.org/10.1016/0002-9343(77)90876-2
   PubMed Web of Science ®Google Scholar
• Cordonnier C, Buzyn A, Leverger G, Herbrecht R, Hunault M, Leclercq R, Bastuji-Garin S. Club de Réflexion sur les Infections en Onco-Hématologie. Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy. Clin Infect Dis 2003; 36:149-58; PMID:12522746; http://dx.doi.org/10.1086/345435
   PubMed Web of Science ®Google Scholar
• Montassier E, Batard E, Gastinne T, Potel G, de La Cochetière MF. Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis 2013; 32:841-50; PMID:23354675; http://dx.doi.org/10.1007/s10096-013-1819-7
   PubMed Web of Science ®Google Scholar
• Mikulska M, Viscoli C, Orasch C, Livermore DM, Averbuch D, Cordonnier C, Akowa M. Fourth European Conference on Infections in Leukemia Group (ECIL-4), a joint venture of EBMT, EORTC, ICHS, ELN and ESGICH/ESCMID. J Infect 2014; 68:321-31; PMID:24370562; http://dx.doi.org/10.1016/j.jinf.2013.12.006
   PubMed Web of Science ®Google Scholar
• Gudiol C, Carratalà J. Antibiotic resistance in cancer patients. Expert Rev Anti Infect Ther 2014; 12:1003-16; PMID:24834465; http://dx.doi.org/10.1586/14787210.2014.920253
   PubMed Web of Science ®Google Scholar
• Trecarichi EM, Tumbarello M. Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact. Curr Opin Infect Dis 2014; 27:200-10; PMID:24573013; http://dx.doi.org/10.1097/QCO.0000000000000038
   PubMed Web of Science ®Google Scholar
• Marín M, Gudiol C, García-Vidal C, Ardanuy C, Carratalà J. Bloodstream infections in patients with solid tumors: Epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center. Medicine 2014; 93:143-9; http://dx.doi.org/10.1097/MD.0000000000000026
   PubMed Web of Science ®Google Scholar
• Anatoliotaki M, Valatas MV, Mantadakis E, Apostolakou H, Mavroudis D, Georgoulias V, Rolston KV, Kontoyiannis DP, Galanakis E, Samonis G. Bloodstream infections in patients with solid tumors: associated factors, microbial spectrum and outcome. Infection 2004; 32:65-71; PMID:15057569; http://dx.doi.org/10.1007/s15010-004-3049-5
   PubMed Web of Science ®Google Scholar
• Ohmagari N, Hanna H, Gravis L, Hackett B, Perego C, Gonzalez V, et al. Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer. Cancer 2005; 104:205-12; PMID:15880433; http://dx.doi.org/10.1002/cncr.21115
   PubMed Web of Science ®Google Scholar
• Martino R, Gomez L, Pericas R, Salazar R, Sola C, Sierra J, Garau J. Bacteremia caused by non-glucose-fermenting gram-negative bacilli and Aeromonas species in patients with haematological malignancies and solid tumours. Eur J Clin Microbiol Infect Dis 2000; 19:320-3; PMID:10834826; http://dx.doi.org/10.1007/s100960050485
   PubMed Web of Science ®Google Scholar
• Chiang MC, Kuo SC, Chen SJ, Yang SP, Lee YT, Chen TL, Fung CP. Clinical characteristics and outcomes of bacteremia due to different genomic species of Acinetobacter baumannii complex in patients with solid tumors. Infection 2012; 40:19-26; PMID:21887526; http://dx.doi.org/10.1007/s15010-011-0187-4
   PubMed Web of Science ®Google Scholar
• Wu HS, Kuo SC, Lee YT, Yang YS, Cheng SS, Chen TL, Fung CP. Clinical characteristics and prognostic factors of Acinetobacter nosocomialis bacteraemia in patients with solid tumors. Clin Microbiol Infect 2012; 18:E373-6; PMID:22712825; http://dx.doi.org/10.1111/j.1469-0691.2012.03927.x
   PubMed Web of Science ®Google Scholar
• Klastersky J, Paesmans M, Ruberstein EB, Boyer M, Elting L, Feld R, Gallagher J, Herrstedt J, Rapoport B, Rolston K, et al. The Multinational Association for Supportive Care in Cancer Risk Index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 2000; 18:3038-51; PMID:10944139
   PubMed Web of Science ®Google Scholar
• Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011; 52:e56-93; PMID:21258094; http://dx.doi.org/10.1093/cid/cir073
   PubMed Web of Science ®Google Scholar
• Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovivi L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 2010; 54:4851-63; PMID:20733044; http://dx.doi.org/10.1128/AAC.00627-10
   PubMed Web of Science ®Google Scholar
• Carmona-Bayonas A, Jiménez-Fonseca P, Virizuela Echaburu J, Antonio M, Font C, Biosca M, Ramchandani A, Martínez J, Hernando Cubero J, Espinosa J, et al. Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study. J Clin Oncol 2015; 33:465-71; PMID:25559804; http://dx.doi.org/10.1200/JCO.2014.57.2347
   PubMed Web of Science ®Google Scholar
• Gudiol C, Calatayud L, Garcia-Vidal C, Lora-Tamayo J, Cisnal M, Duarte R, Arnan M, Marin M, Carratalà J, Gudiol F. Bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, riSsk factors, molecular epidemiology and outcome. J Antimicrob Chemother 2010; 65:333-41; PMID:19959544; http://dx.doi.org/10.1093/jac/dkp411
   PubMed Web of Science ®Google Scholar
• Gudiol C, Tubau F, Calatayud L, Garcia-Vidal C, Cisnal M, Sánchez-Ortega I, Duarte R, Calvo M, Carratalà J. Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother 2011; 66:657-63; PMID:21193475; http://dx.doi.org/10.1093/jac/dkq494
   PubMed Web of Science ®Google Scholar
• Joo EJ, Kang CI, Ha YE, Kim J, Kang SJ, Park SY, Lee NY, Wi YM, Chung DR, Peck KR, et al. Clincial predictors of Pseudomonas aeruginosa bacteremia among Gram-negative bacterial infections in non-neutropenic patients with solid tumors. J Infect 2011; 63:207-14; PMID:21777616; http://dx.doi.org/10.1016/j.jinf.2011.06.011
   PubMed Web of Science ®Google Scholar
• Chen IC, Hsu C, Chen YC, Chien SF, Kao HF, Chang SY, Hu FC, Yeh KH. Predictors of bloodstream infections associated with permanently implantable venous port in solid cancer patients. Ann Oncol 2013; 24:463-8; PMID:23059959; http://dx.doi.org/10.1093/annonc/mds468
   PubMed Web of Science ®Google Scholar
• Maki DG, Kluger DM, Cnich CJ. The risk of bloodstream infection in adults with different intravascular devices. A systematic review of 200 published prospective studies. Mayo Clin Proc 2006; 81:1159-71; PMID:16970212; http://dx.doi.org/10.4065/81.9.1159
   PubMed Web of Science ®Google Scholar
• O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011; 52:e162-193; PMID:21460264; http://dx.doi.org/10.1093/cid/cir257
   PubMed Web of Science ®Google Scholar
• Kao HF, Chen IC, Hsu CH, Chang SY, Chien SF, Chen YC, Hu FC, Yang JCH, Cheng AL, Yeh KH. Chlorhexidine for the prevention of bloodstream infection associated with totally implantable ports in patients with solid cancer. Support Care Cancer 2014; 22:1189-97; PMID:24384684; http://dx.doi.org/10.1007/s00520-013-2071-5
   PubMed Web of Science ®Google Scholar
• Schiffer CA, Mangu PB, Wade JC, Camp-Sorrell D, Cope DG, El-Rayes BF, Gorman M, Ligibel J, Mansfield P, Levine M. Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 2013; 31:1357-70; PMID:23460705; http://dx.doi.org/10.1200/JCO.2012.45.5733
   PubMed Web of Science ®Google Scholar
• Carratalà J, Niubó J, Fernández-Sevilla A, Juvé E, Castellsagué X, Berlanga J, Liñares J, Gudiol F. Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother 1999; 43:2200-4
   PubMed Web of Science ®Google Scholar
• van de Wetering MD, van Woensel JB, Lawrie TA. Prohpylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patients. Cochrane database Syst Rev 2013; 11:CD003295
   PubMedGoogle Scholar
• Ranson MR, Oppenheim BA, Jackson A, Kamthan AG, Scarffe JH. Double.blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. J Hosp Infect 1990; 15: 95-102; PMID:1968484; http://dx.doi.org/10.1016/0195-6701(90)90025-J
   PubMed Web of Science ®Google Scholar
• Cullen M, Steven N, Billingham L, Gaunt C, Hastings M, Simmonds P, Stuart N, Rea D, Bower M, Fernando I. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med 2005; 353:988-98; PMID:16148284; http://dx.doi.org/10.1056/NEJMoa050078
   PubMed Web of Science ®Google Scholar
• Gafter.Gvili A, Fraser A, Paul MLeibovici L. Meta.analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med 2005; 142:979-95; PMID:15968013; http://dx.doi.org/10.7326/0003-4819-142-12_Part_1-200506210-00008
   PubMed Web of Science ®Google Scholar
• Flowers CR, Seidenfeld J, Bow EJ, Karten C, Gleason C, Hawley DK, Kuderer NM, Langston AA, Marr KA, Rolston KV, et al. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American society of clinical oncology clinical practice guideline. J Clin Oncol 2013; 31:794-810; PMID:23319691; http://dx.doi.org/10.1200/JCO.2012.45.8661
   PubMed Web of Science ®Google Scholar
• Neumann S, Krause SW, Maschmeyer G, Schiel Xvon Lilienfeld.Toal M. Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2013; 92:433-42; PMID:23412562; http://dx.doi.org/10.1007/s00277-013-1698-0
   PubMed Web of Science ®Google Scholar
• Kuderer NM, Dale DC, Crawford J, Lyman GH. Impact of primary prophylaxis with granulocyte colony.stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review. J Clin Oncol 2007; 25:3158-67; PMID:17634496; http://dx.doi.org/10.1200/JCO.2006.08.8823
   PubMed Web of Science ®Google Scholar
• Crawford J, Caserta Croila F. Hematopoietic growth factors: ESMO Clinical Practice Guidelines for the applications. Ann Oncol 2010; 21 Suppl 5:v248-251; PMID:20555091; http://dx.doi.org/10.1093/annonc/mdq195
   PubMed Web of Science ®Google Scholar
• Clark OA, Lyman GH, Castro AA, Clark LG, Djulbegovic B. Colony.stimulating factors for chemotherapy.induced febrile neutropenia: a meta.analysis of randomized controlled trials. J Clin Oncol 2005; 23:4198-214; PMID:15961767; http://dx.doi.org/10.1200/JCO.2005.05.645
   PubMed Web of Science ®Google Scholar
• Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 2006; 106:2258-66; PMID:16575919; http://dx.doi.org/10.1002/cncr.21847
   PubMed Web of Science ®Google Scholar
• Garcia.Vidal C, Ardanuy C, Gudiol C, Cuervo G, Calatayud L, Bodro M, Duarte R, Fernández.Sevilla A, Antonio M, Liñares J, et al. Clinical and microbiological epidemiology of streptococcus pneumoniae bacteremia in cancer patients. J Infect 2012; 65:521-7; PMID:22954752; http://dx.doi.org/10.1016/j.jinf.2012.08.015
   PubMed Web of Science ®Google Scholar
• Kumar D, Chen MH, Welsh B, Siegal D, Cobos I, Messner HA, Lipton J, Humar A. A randomized, double blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients. Clin Infect Dis 2007; 45:1576-82; PMID:18190318; http://dx.doi.org/10.1086/523583
   PubMed Web of Science ®Google Scholar